BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3510682)

  • 1. Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz D; Martin P
    Blood; 1986 Feb; 67(2):509-15. PubMed ID: 3510682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection of viable cell populations using avidin-biotin immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz D
    J Immunol Methods; 1986 Jul; 91(1):11-9. PubMed ID: 3088123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.
    Tassi C; Fortuna A; Bontadini A; Lemoli RM; Gobbi M; Tazzari PL
    Haematologica; 1991 Mar; 76 Suppl 1():41-3. PubMed ID: 1713873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption.
    Lemoli RM; Gobbi M; Tazzari PL; Tassi TC; Dinota A; Visani G; Grassi G; Mazza P; Cavo M; Tura S
    Transplantation; 1989 Feb; 47(2):385-7. PubMed ID: 2645722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment of dogs with Ia-positive marrow cells isolated by avidin-biotin immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz D; Schuening F; Deeg HJ; Graham T; Storb R
    Blood; 1987 May; 69(5):1363-7. PubMed ID: 2952184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surface antigen labeling on spleen colony formation: comparison of the indirect immunofluorescence and the biotin-avidin methods.
    Bauman JG; Mulder AH; van den Engh GJ
    Exp Hematol; 1985 Sep; 13(8):760-7. PubMed ID: 3930275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purging of T-lymphocytes with magnetic affinity colloid.
    Yau JC; Reading CL; Thomas MW; Davaraj BM; Tindle SE; Jagannath S; Dicke KA
    Exp Hematol; 1990 Mar; 18(3):219-22. PubMed ID: 2303117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell sorting of lymphocyte subpopulations by biotinylated antibody and avidin-Sepharose beads.
    Cone RE; Chi T
    J Exp Pathol; 1985; 2(3):165-9. PubMed ID: 3916105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific selection of lymphocyte subpopulations by avidin-biotin immune rosetting.
    Lucas PJ; Gress RE
    J Immunol Methods; 1987 May; 99(2):185-90. PubMed ID: 3108407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
    Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
    Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immunoabsorption using monoclonal antibodies. Selective removal of T cells from peripheral blood and bone marrow.
    Berenson RJ; Levitt LJ; Levy R; Miller RA
    Transplantation; 1984 Aug; 38(2):136-42. PubMed ID: 6380041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
    Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
    J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells.
    Tomita M; Tsong TY
    Biochim Biophys Acta; 1990 Dec; 1055(3):199-206. PubMed ID: 2265207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An avidin-biotin ELISA assay for the measurement of de novo human IgE synthesis in culture supernatants.
    Alevy YG; Blynn CM
    J Immunol Methods; 1986 Mar; 87(2):273-81. PubMed ID: 3485159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
    Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
    Shimazaki C; Wisniewski D; Scheinberg DA; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang CY; Clarkson BD
    Blood; 1988 Oct; 72(4):1248-54. PubMed ID: 3167207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptavidin-biotin immunotoxins: a new approach to purging bone marrow.
    Meyer BF; Stoner ML; Raphael CL; Davis RE; Herrmann RP
    Exp Hematol; 1991 Aug; 19(7):710-3. PubMed ID: 1893957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purging tumor cells from bone marrow or peripheral blood using avidin-biotin immunoadsorption.
    Stray KM; Corpuz S; Kalamasz D; Colter M; Berenson R; Heimfeld S
    Prog Clin Biol Res; 1994; 389():97-103. PubMed ID: 7535467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.